TPM4 and prostate cancer: In this context, differences in protein expression (SATB1, SPIN1, TBB5, VIME, TPM4) between benign prostate tissue and prostate cancer with respect to clinicopathological risk factors, tumor heterogeneity and genomic instability were assessed.